{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-075279","form_type":"8-K","ticker":"ARMP","cik":"0000921114","company_name":"Armata Pharmaceuticals, Inc.","filed_at":"2023-06-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:42.818629+00:00","generated_at":"2026-06-13T16:43:26.276096+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Armata sets 2023 annual meeting for Aug 29; proposal deadline July 7","bullets":["Annual meeting on August 29, 2023, at 8:30 a.m. local time at principal offices in Marina del Rey, CA.","Record date for stockholders to vote is July 10, 2023.","Deadline for stockholder proposals under Rule 14a-8 and director nominations is July 7, 2023 at 5:00 p.m. ET.","Meeting date is more than 30 days from 2022 annual meeting, triggering new deadlines.","Proposals and nominations must be submitted in writing to the Corporate Secretary."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-075279","json":"https://secwatch.observer/filing/0001104659-23-075279.json","markdown":"https://secwatch.observer/filing/0001104659-23-075279.md","text":"https://secwatch.observer/filing/0001104659-23-075279.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/921114/000110465923075279/0001104659-23-075279-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/921114/000110465923075279/tm2319681d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T16:43:26.276096+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}